This important study introduces a new biology-informed strategy for deep learning models aiming to predict mutational effects in antibody sequences. It provides solid evidence that separating ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

AI therapeutics company built on causal biology, today announced the acquisition of CombinAbleAI and the launch of insitro's TherML™ (Therapeutic Machine Learning) platform. The acquisition, which is ...

North America Captures a Significant Revenue Share in the Automated Machine Learning Market, Supported by Government-Backed ...

Machine learning is reshaping the way portfolios are built, monitored, and adjusted. Investors are no longer limited to ...